Zacks Investment Research
27 Oct 2026, 16:51 UTC · 1h ago
Impact · against what's priced in
Novartis shows positive operating leverage with core operating income growing 11% despite a slight revenue miss and heavy generic pressure on Entresto. While the EPS beat is positive, the top-line miss suggests growth may be peaking across key brands.
No priced-in read yet
What the story claims
5 claims · scored −1 bearish … +1 bullish · 5 new · 0 priced in
Novartis reported Q3 2026 core earnings per share of $2.46, beating the Zacks Consensus Estimate of $2.25.
Newreported October 27, 2026
So whatThe 9% YoY EPS growth suggests a strengthening bottom line that may drive an upward revision of FY2026 earnings estimates.
More positive than 93% of claims this week
Core operating income increased 11% to $6.04 billion.
Continue reading
5 related stories
Core EPS of $2.46 beat estimates and grew 9% YoY, supported by an 11% increase in core operating income, though revenue slightly missed expectations at $14.52 billion.
Read from the article alone
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Newreported October 27, 2026
So whatOperating income grew faster than revenue (11% vs 4%), indicating successful margin expansion during the quarter.
More positive than 86% of claims this week
Sales of the cardiovascular drug Entresto plunged 38% to $1.17 billion due to generic competition.
Newreported October 27, 2026
More negative than 87% of claims this week
Q3 2026 revenues of $14.52 billion missed the Zacks Consensus Estimate of $14.56 billion by 0.2%.
Newreported October 27, 2026
So whatThe top-line miss, despite a 4% YoY increase, suggests growth may be peaking across priority brands.
More negative than 79% of claims this week
Kisqali sales surged 37% to $1.82 billion, although this missed the Zacks Consensus Estimate of $1.85 billion.
Newreported October 27, 2026
More positive than 64% of claims this week
Which stocks this story touches
More positive than 77% of ticker scores this week
The company reported a beat on core earnings per share and core net income growth, with the stock rising in pre-market trading.
More positive than 47% of ticker scores this week
Listed as having significant page view growth over the last 3 trading days.
More positive than 47% of ticker scores this week
Ranked second in total page views over the last 7 trading days.
More positive than 47% of ticker scores this week
Listed as having significant page view growth over the last 3 trading days.
More positive than 47% of ticker scores this week
Listed as having significant page view growth over the last 3 trading days.
More positive than 47% of ticker scores this week
Mentioned as having the highest total page views and highest page view growth, indicating high investor interest.
More positive than 47% of ticker scores this week
Listed as having significant page view growth over the last 3 trading days.
More positive than 47% of ticker scores this week
Ranked fifth in total page views over the last 7 trading days.
More positive than 47% of ticker scores this week
Ranked seventh in total page views over the last 7 trading days.
More positive than 47% of ticker scores this week
Ranked third in total page views over the last 7 trading days.
More positive than 47% of ticker scores this week
Listed as having significant page view growth over the last 3 trading days.
More positive than 47% of ticker scores this week
Listed as having significant page view growth over the last 3 trading days.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
2h ago
+1.3%
Price agrees with the score
$155.81 vs $153.81 close before publication (Oct 26) · not market-adjusted
NVS chart →
